Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	647	$985.62	837,500
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	53	$984.02	838,147
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	727	$983.88	838,200
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	303	$982.29	838,927
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	2,283	$981.52	839,230
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	1,223	$980.72	841,513
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	504	$979.87	842,736
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	4,865	$978.44	843,240
May 01, 2012	YANCOPOULOS GEORGE Director, EVP CSO President Regeneron Re Trans History: 673	Director, EVP CSO President Regeneron Re	Form 4	Open market or private sale of non-derivative or derivative security	20,120	$134.54	845,986
May 15, 2024	YANCOPOULOS GEORGE Director, Bd. Co-Chair, President & CSO Trans History: 673	Director, Bd. Co-Chair, President & CSO	Form 4	Open market or private sale of non-derivative or derivative security	9,851	$977.42	848,105

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media